Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 8/2020

01-08-2020 | Obesity | Review

Antiemetic Prophylaxis and Anesthetic Approaches to Reduce Postoperative Nausea and Vomiting in Bariatric Surgery Patients: a Systematic Review

Authors: Zaina Naeem, Ingrid L. Chen, Aurora D. Pryor, Salvatore Docimo, Tong J. Gan, Konstantinos Spaniolas

Published in: Obesity Surgery | Issue 8/2020

Login to get access

Abstract

While guidelines exist for the management of postoperative nausea and vomiting (PONV) in the general surgical setting, there are no established guidelines for the prevention or treatment of PONV in bariatric patients, in whom PONV contributes significantly to perioperative morbidity and hospital resource utilization. This systematic review found that the multimodal pharmacological approach to PONV prevention recommended in current guidelines for high-risk surgical patients is appropriate for the bariatric subset. This includes multi-agent antiemetic prophylaxis with dexamethasone and one or more agents from other classes, and opioid-free total intravenous anesthesia, though the advantages of the latter need further evaluation. There remains a need for a standardized validated instrument to assess PONV in the bariatric setting.
Literature
1.
Mendes MN, Monteiro RS, Martins FANC. Prophylaxis of postoperative nausea and vomiting in morbidly obese patients undergoing laparoscopic gastroplasties. A comparative study among three methods. Rev Bras Anestesiol. 2009;59(5):570–6.PubMed
2.
Fathy M, Abdel-Razik MA, Elshobaky A, et al. Impact of pyloric injection of magnesium sulfate-lidocaine mixture on postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a randomized-controlled trial. Obes Surg. 2019;29(5):1614–23.PubMedCrossRef
3.
Celio A, Bayouth L, Burruss MB, et al. Prospective assessment of postoperative nausea early after bariatric surgery. Obes Surg. 2019;29(3):858–61.PubMedCrossRef
4.
Markic J, Ridge AL. Promethazine in the treatment of postoperative nausea and vomiting: a systematic review. Signa Vitae. 2011;6(2):9–16.CrossRef
5.
Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting. Anesthesiology. 1999;91:693–700.PubMedCrossRef
6.
Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113.PubMedCrossRef
7.
Sinha AC, Singh PM, Williams NW, et al. Aprepitant’s prophylactic efficacy in decreasing postoperative nausea and vomiting in morbidly obese patients undergoing bariatric surgery. Obes Surg. 2013;24(2):225–31.CrossRef
8.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.PubMedPubMedCentralCrossRef
9.
Groene P, Eisenlohr J, Zeuzem C, et al. Postoperative nausea and vomiting in bariatric surgery in comparison to non-bariatric gastric surgery. Wideochir Inne Tech Maloinwazyjne. 2019;14(1):90–5.PubMed
10.
Moussa AA, Oregan PJ. Prevention of postoperative nausea and vomiting in patients undergoing laparosopic bariatric surgery: granisetron alone vs granisetron combined with dexamethasone/droperidol. MEJ Anesth. 2007;19(2):357–68.
11.
Benevides ML, Oliveira SS, de Aguilar-Nascimento JE. The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. Obes Surg. 2013;23(9):1389–96.PubMedCrossRef
12.
Didehvar S, Viola-Blitz JD, Haile M, et al. A randomized, double blind study to evaluate the efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of post-operative nausea and vomiting in subjects undergoing bariatric surgeries with high emetogenic risk. The Open Anesthesiology Journal. 2013;7:30–6.CrossRef
13.
Bataille A, Letourneulx JF, Charmeau A, et al. Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: a randomised double-blind placebo-controlled study. Eur J Anaesthesiol. 2016;33(12):898–905.PubMedCrossRef
14.
Halliday TA, Sundqvist J, Hultin M, et al. Post-operative nausea and vomiting in bariatric surgery patients: an observational study. Acta Anaesthesiol Scand. 2017;61(5):471–9.PubMedCrossRef
15.
Therneau IW, Martin EE, Sprung J, et al. The role of aprepitant in prevention of postoperative nausea and vomiting after bariatric surgery. Obes Surg. 2017;28(1):37–43.CrossRef
16.
Zhao LP, Zou LJ, He JH. Postoperative vomiting/nausea in Chinese patients undergoing bariatric surgery. Trop J Pharm Res. 2019;18(10):2211–7.CrossRef
17.
Suh S, Helm M, Kindel TL, Goldblatt MI, Gould JC, Higgins RM. The impact of nausea on post-operative outcomes in bariatric surgery patients. Surg Endosc. 2019.
18.
Ziemann-Gimmel P, Goldfarb AA, Koppman J, et al. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014;112(5):906–11.PubMedCrossRef
19.
Nordin L, Nordlund A, Lindqvist A, et al. Corticosteroids or not for postoperative nausea: a double-blinded randomized study. J Gastrointest Surg. 2016;20(8):1517–22.PubMedCrossRef
20.
Boogaerts JG, Vanacker E, Seidel L, et al. Assessment of postoperative nausea using a visual analogue scale. Acta Anaesthesiol Scand. 2000;44:470–4.PubMedCrossRef
21.
Aftab H, Fagerland MW, Gondal G, et al. Pain and nausea after bariatric surgery with total intravenous anesthesia versus desflurane anesthesia: a double blind, randomized, controlled trial. Surg Obes Relat Dis. 2019;15(9):1505–12.PubMedCrossRef
22.
Bamgbade OA, Oluwole O, Khaw RR. Perioperative antiemetic therapy for fast-track laparoscopic bariatric surgery. Obes Surg. 2018;28(5):1296–301.PubMedCrossRef
23.
Ziemann-Gimmel P, Hensel P, Koppman J, et al. Multimodal analgesia reduces narcotic requirements and antiemetic rescue medication in laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2013;9(6):975–80.PubMedCrossRef
24.
Myles PS, Wengritzky R. Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review. Br J Anaesth. 2012;108(3):423–9.PubMedCrossRef
25.
Talebpour M, Ghiasnejad Omrani N, Imani F, et al. Comparison effect of promethazine/dexamethasone and metoclopramide /dexamethasone on postoperative nausea and vomiting after laparascopic gastric placation: a randomized clinical trial. Anesth Pain Med. 2017;7(4):e57810.PubMedPubMedCentralCrossRef
26.
Lindley CM, Hirsch JD, O'Neill CV, et al. Quality of life consequences of chemotherapy-induced emesis. Qual Life Res. 1992;1(5):331–40.PubMedCrossRef
27.
Alimian M, Abedian AE, Entezari S, et al. Comparison of the effect of intraoperative 1 mg/kg/h and 2 mg/kg/h IV lidocaine infusion on postoperative pain and nausea-vomiting in laparoscopic gastric bypass surgery. Journal of Pharmaceutical Research International. 2019:1–9.
28.
Schuster R, Alami RS, Curet MJ, et al. Intra-operative fluid volume influences postoperative nausea and vomiting after laparoscopic gastric bypass surgery. Obes Surg. 2006;16:848–51.PubMedCrossRef
29.
Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000;92:958–67.PubMedCrossRef
30.
Kim EJ, Ko JS, Kim CS, et al. Combination of antiemetics for the prevention of postoperative nausea and vomiting in high-risk patients. J Korean Med Sci. 2007;22:878–82.PubMedPubMedCentralCrossRef
31.
Delgado DA, Lambert BS, Boutris N, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2018;2(3):e088.PubMedPubMedCentral
32.
Rhodes VA, McDaniel RW. The index of nausea, vomiting, and retching: a new format of the index of nausea and vomiting. Oncol Nurs Forum. 1999;26(5):889–94.PubMed
33.
Afaneh C, Costa R, Pomp A, et al. A prospective randomized controlled trial assessing the efficacy of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative gastrointestinal symptoms. Surg Endosc. 2015;29(1):41–7.PubMedCrossRef
34.
Hauser JM, Azzam JS, Kasi A. Antiemetic Medications. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [Updated 2019 Nov 25].
35.
Pierre S, Whelan R. Nausea and vomiting after surgery. Continuing Education in Anaesthesia Critical Care & Pain. 2013;13(1):28–32.CrossRef
36.
Bergese SD, Antor MA, Uribe AA, et al. Triple therapy with scopolamine, ondansetron, and dexamethasone for prevention of postoperative nausea and vomiting in moderate to high-risk patients undergoing craniotomy under general anesthesia: a pilot study. Front Med (Lausanne). 2015;2:40.
37.
Chatterjee S, Rudra A, Sengupta S. Current concepts in the management of postoperative nausea and vomiting. Anesthesiol Res Pract. 2011;2011:748031.PubMedPubMedCentral
38.
Antor MA, Uribe AA, Erminy-Falcon N, et al. The effect of transdermal scopolamine for the prevention of postoperative nausea and vomiting. Front Pharmacol. 2014;5
39.
Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth. 2012;109(5):742–53.PubMedCrossRef
40.
Apfel CC, Stoecklein K, Lipfert P. PONV: a problem of inhalational anaesthesia? Best Pract Res Clin Anaesthesiol. 2005;19(3):485–500.PubMedCrossRef
41.
Junger A, Hartmann B Fau-Benson M, Benson M Fau-Schindler E, et al. The use of an anesthesia information management system for prediction of antiemetic rescue treatment at the postanesthesia care unit. (0003-2999 (Print)).
42.
White PF, O'Hara JF, Roberson CR, et al. The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients. Anesth Analg. 2008;107(2):452–8.PubMedCrossRef
43.
Alimian M, Imani F, Faiz SH, et al. Effect of oral pregabalin premedication on post-operative pain in laparoscopic gastric bypass surgery. Anesth Pain Med. 2012;2(1):12–6.PubMedPubMedCentralCrossRef
44.
Wojcikiewicz TG, Jeans J, Karmali A, et al. The use of high-dose intrathecal diamorphine in laparoscopic bariatric surgery: a single-centre retrospective cohort study. Br J Pain. 2019;13(2):106–11.PubMedCrossRef
45.
Symons JL, Kemmeter PR, Davis AT, et al. A double-blinded, prospective randomized controlled trial of intraperitoneal bupivacaine in laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2007;204(3):392–8.PubMedCrossRef
46.
Ruiz-Tovar J, Garcia A, Ferrigni C, et al. Impact of implementation of an enhanced recovery after surgery (ERAS) program in laparoscopic Roux-en-Y gastric bypass: a prospective randomized clinical trial. Surg Obes Relat Dis. 2019;15(2):228–35.PubMedCrossRef
47.
Major P, Stefura TA, Malczak P, et al. Postoperative care and functional recovery after laparoscopic sleeve gastrectomy vs. laparoscopic Roux-en-Y gastric bypass among patients under ERAS protocol. Obes Surg. 2018;28(4):1031–9.PubMedCrossRef
48.
King AB, Spann MD, Jablonski P, et al. An enhanced recovery program for bariatric surgical patients significantly reduces perioperative opioid consumption and postoperative nausea. Surg Obes Relat Dis. 2018;14(6):849–56.PubMedCrossRef
Metadata
Title
Antiemetic Prophylaxis and Anesthetic Approaches to Reduce Postoperative Nausea and Vomiting in Bariatric Surgery Patients: a Systematic Review
Authors
Zaina Naeem
Ingrid L. Chen
Aurora D. Pryor
Salvatore Docimo
Tong J. Gan
Konstantinos Spaniolas
Publication date
01-08-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 8/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04683-1

Other articles of this Issue 8/2020

Obesity Surgery 8/2020 Go to the issue

Original Contributions

Chronic Abdominal Pain After Previous Bariatric Surgery: Consider the Abdominal Wall

Letter to the Editor

Letter to the Editor: Intragastric Balloon Removal During the COVID-19 Pandemic: to Postpone or Not? That Is the Question

Original Contributions

Ameliorating Effects and Mechanisms of Intra-Operative Vagal Nerve Stimulation on Postoperative Recovery After Sleeve Gastrectomy in Rats

Original Contributions

A French National Study on Gastropleural and Gastrobronchial Fistulas After Bariatric Surgery: the Impact of Therapeutic Strategy on Healing

Original Contributions

Laparoscopic Adjustable Gastric Banding—Should a Second Chance Be Given?

Correction

Correction to: Endoscopic Argon Plasma Coagulation Vs. Multidisciplinary Evaluation in the Management of Weight Regain after Gastric Bypass Surgery: a Randomized Controlled Trial with SHAM Group